Moberg Pharma Valuation
| MOB Stock | SEK 18.11 0.60 3.21% |
At this time, the firm appears to be overvalued. Moberg Pharma AB secures a last-minute Real Value of kr15.92 per share. The latest price of the firm is kr18.11. Our model forecasts the value of Moberg Pharma AB from analyzing the firm fundamentals such as Shares Outstanding of 98.27 M, operating margin of (97.71) %, and Return On Equity of -0.0325 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Moberg Pharma's price fluctuation is slightly risky at this time. Calculation of the real value of Moberg Pharma AB is based on 3 months time horizon. Increasing Moberg Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Moberg Pharma's intrinsic value may or may not be the same as its current market price of 18.11, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.11 | Real 15.92 | Hype 18.11 |
The intrinsic value of Moberg Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Moberg Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Moberg Pharma AB helps investors to forecast how Moberg stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Moberg Pharma more accurately as focusing exclusively on Moberg Pharma's fundamentals will not take into account other important factors: Moberg Pharma Total Value Analysis
Moberg Pharma AB is now forecasted to have takeover price of 82.88 M with market capitalization of 272.28 M, debt of 16.25 M, and cash on hands of 36.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Moberg Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
82.88 M | 272.28 M | 16.25 M | 36.6 M |
Moberg Pharma Investor Information
About 18.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Moberg Pharma AB recorded a loss per share of 0.36. The entity last dividend was issued on the 4th of November 2019. The firm had 10:1 split on the 24th of May 2023. Based on the key measurements obtained from Moberg Pharma's financial statements, Moberg Pharma AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Moberg Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Moberg Pharma has an asset utilization ratio of 46.5 percent. This implies that the Company is making kr0.47 for each dollar of assets. An increasing asset utilization means that Moberg Pharma AB is more efficient with each dollar of assets it utilizes for everyday operations.Moberg Pharma Ownership Allocation
Moberg Pharma AB maintains a total of 98.27 Million outstanding shares. Moberg Pharma AB secures 18.07 % of its outstanding shares held by insiders and 3.39 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Moberg Pharma Profitability Analysis
The company reported the revenue of 209.68 M. Net Income was 7.49 M with profit before overhead, payroll, taxes, and interest of 207 K.About Moberg Pharma Valuation
The stock valuation mechanism determines Moberg Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Moberg Pharma AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Moberg Pharma. We calculate exposure to Moberg Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Moberg Pharma's related companies.Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. Moberg Pharma operates under Drug ManufacturersSpecialty Generic classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people.
8 Steps to conduct Moberg Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Moberg Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Moberg Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Moberg Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Moberg Pharma's revenue streams: Identify Moberg Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Moberg Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Moberg Pharma's growth potential: Evaluate Moberg Pharma's management, business model, and growth potential.
- Determine Moberg Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Moberg Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.